Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Appointed director
|
|
RELMADA THERAPEUTICS, INC. (RLMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| TRAVERSA SERGIO (CEO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 527,211 options to buy
@ $3.37, valued at
$1.8M
|
|
| 05/30/2023 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 317,643 options to buy
@ $3.37, valued at
$1.1M
|
|
| 05/30/2023 |
4
| SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 92,958 options to buy
@ $3.37, valued at
$313.3k
|
|
| 05/30/2023 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 92,958 options to buy
@ $3.37, valued at
$313.3k
|
|
| 05/30/2023 |
4
| GLASSPOOL JOHN (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 92,958 options to buy
@ $3.37, valued at
$313.3k
|
|
| 05/30/2023 |
4
| Fedeli Fabiana (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 200,000 options to buy
@ $4.22, valued at
$844k
|
|
| 05/30/2023 |
4
| Ence Chuck (CA and CO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 321,238 options to buy
@ $3.37, valued at
$1.1M
|
|
| 05/30/2023 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 92,958 options to buy
@ $3.37, valued at
$313.3k
|
|
| 05/24/2023 |
4
| O'Gorman Cedric (Chief Medical Officer) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Bought 10,000 shares
@ $3.18, valued at
$31.8k
|
|
| 01/13/2023 |
4
| O'Gorman Cedric (Chief Medical Officer) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 400,000 options to buy
@ $3.29, valued at
$1.3M
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Disposed of 200,000 options to buy
@ $19.03, valued at
$3.8M
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 194,917 options to buy
@ $3.37, valued at
$656.9k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 57,042 options to buy
@ $3.37, valued at
$192.2k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 182,470 options to buy
@ $19.03, valued at
$3.5M
|
|
| 05/26/2022 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 295,211 options to buy
@ $19.03, valued at
$5.6M
Granted 200,000 options to buy
@ $19.03, valued at
$3.8M
|
|
| 05/26/2022 |
4
| GLASSPOOL JOHN (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 91,235 options to buy
@ $19.03, valued at
$1.7M
|
|
| 05/26/2022 |
4
| SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 91,235 options to buy
@ $19.03, valued at
$1.7M
|
|
| 05/26/2022 |
4
| Ence Chuck (CA and Compliance Officer) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 295,404 options to buy
@ $19.03, valued at
$5.6M
Granted 200,000 options to buy
@ $19.03, valued at
$3.8M
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $30.0395, valued at
$300.4k
Exercised 10,000 options to buy
@ $3.24, valued at
$32.4k
|
|
| 04/05/2022 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 3,300 shares
@ $29, valued at
$95.7k
Exercised 19,800 options to buy
@ $3.24, valued at
$64.2k
|
|
| 01/05/2022 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Exercised 20,000 options to buy
@ $3.24, valued at
$64.8k
|
|
| 12/21/2021 |
4
| TRAVERSA SERGIO (CEO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 492,173 options to buy
@ $19.03, valued at
$9.4M
|
|
| 12/21/2021 |
4
| GLASSPOOL JOHN (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 58,765 options to buy
@ $19.03, valued at
$1.1M
|
|
|
|
|